Showing results (121-130 of 176) with videos related to
Sort By:
Pageof 18
The Journal of Infectious Diseases|June 10, 2020
Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1Yasue Takeuchi, Masataka Tsuge, Ken Tsushima, et al.Antimicrobial Agents and Chemotherapy|May 26, 2010
Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis BFukiko Mitsui, Masataka Tsuge, Takashi Kimura, et al.Clinical Journal of Gastroenterology|November 17, 2020
A case with life-threatening secondary sclerosing cholangitis caused by nivolumabYuki Yoshikawa, Michio Imamura, Kenji Yamaoka, et al.Idcases|February 8, 2021
A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR systemYuki Yoshikawa, Michio Imamura, Kei Morio, et al.Journal of Proteome Research|February 21, 2025
Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma DevelopmentHikaru Nakahara, Atsushi Ono, C Nelson Hayes, et al.Hepatology (Baltimore, Md.)|June 1, 2011
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivoNobuhiko Hiraga, Michio Imamura, Hiromi Abe, et al.Antimicrobial Agents and Chemotherapy|January 29, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirinEisuke Murakami, Michio Imamura, C Nelson Hayes, et al.The Journal of Infectious Diseases|February 28, 2022
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAILYosuke Suehiro, Masataka Tsuge, Mio Kurihara, et al.Journal of Hepatology|December 15, 2010
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric miceEiji Ohara, Nobuhiko Hiraga, Michio Imamura, et al.Antiviral Therapy|June 2, 2018
Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot studyYumiko Tatsukawa, Masataka Tsuge, Yoshiiku Kawakami, et al.Pageof 18